IN8bio, Inc. INAB
0.93 USD -0.02 (-2.02%)
At closeNov 4, 2026, 4:00 PM EST
0.93 0.00 0.00%
After hours · Nov 4, 4:00 PM ET
0.92 Day range 0.97
0.87 52-week range 2.73
- YTD
- -60.23%
- 1 year
- -43.59%
Financial health
Altman Z-Score
-10.04 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-3 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 3
- P/E 1
- P/B 4
Valuation
P/E -0.5×
FY 2018 5y median -1.4× FY 2025
P/S 0.0×
FY 2018 5y median 0.0× FY 2025
P/B 0.4×
FY 2018 5y median 1.7× FY 2025
P/FCF -0.8×
FY 2018 5y median -1.7× FY 2025
EV/EBITDA 0.8×
FY 2018 5y median -0.9× FY 2025
EV/Sales 0.0×
FY 2018 5y median 0.0× FY 2025
FCF Yield -124.2%
FY 2018 5y median -58.1% FY 2025
Profitability
Gross Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2018 5y median 0.0% FY 2025
ROE -70.5%
FY 2018 5y median -120.3% FY 2025
ROIC -65.5%
FY 2018 5y median -99.7% FY 2025
ROA -60.2%
FY 2018 5y median -86.3% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2018 FY 2025
Operating Income 34.7%
FY 2018 FY 2025
EPS (diluted) 74.0%
FY 2018 FY 2025
Free Cash Flow 47.6%
FY 2018 FY 2025
Financial Health
Current Ratio 8.8×
FY 2018 5y median 4.6× FY 2025
Quick Ratio 8.8×
FY 2018 5y median 4.6× FY 2025
Debt / Equity 0.1×
FY 2018 5y median 0.2× FY 2025
Net Debt / EBITDA 1.4×
FY 2018 5y median 0.6× FY 2025
Interest Coverage 0.0×
FY 2018 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31